Back to search results

Contingency Management for Opioid Use Disorder After Emergency Department Care

This study is looking at a way to help people continue treatment for Opioid Use Disorder (OUD) after starting medication in the emergency department. It's testing if offering payments (called "Contingency Management") for attending outpatient appointments for Medication for Opioid Use Disorder (MOUD) helps more people keep up with their treatment. All participants will receive standard outpatient care. Researchers will compare those who get payments for attendance to those who only receive standard care. The main goal is to see if more people attend their first outpatient MOUD clinic appointment within 30 days. You may be able to join if you're 18 or older, referred to an outpatient clinic after starting buprenorphine or methadone in the emergency department, and plan to stay in the Burlington/Chittenden County area for at least 30 days. The study is currently recruiting about 30 participants.

Study design
This is an interventional study comparing two groups: one receiving Contingency Management (payments for attending appointments) plus usual care, and another receiving only usual care. About 30 adults will be randomly assigned to one of these groups.
What's involved
Not specified in the trial record.
Compensation
Participants in the active arm will receive monetary incentives for outpatient MOUD treatment attendance.
Follow-up
The primary endpoint is measured at 30 days, focusing on attendance at the outpatient MOUD clinic.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07129902

Contingency Management to Improve Medication for Opioid Use Disorder Continuation After the Emergency Department

Recruiting
NAAges 18+InterventionalTreatment
University of Vermont
~30 participants
Updated 2026-05-29 on ClinicalTrials.gov
What's tested:Contingency ManagementUsual care as prescribed by the ED physicians

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Intake at outpatient MOUD clinic
Measured over 30 days

Conditions

Opioid Use Disorder

Explore related trials

Opioid Use Disorder

Where it's being run

1 sites across 1 states
Vermont1

Study leadership

  • Eric A Thrailkill, Ph.D. · PRINCIPAL_INVESTIGATOR · University of Vermont

Who to contact

Eric A Thrailkill, Ph.D.
[email protected]
602-291-7311
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

STAR referral to outpatient clinic (Addiction Treatment Center and Chittenden Clinic) with prescription for buprenorphine or methadone.
Age ≥18 years.
Provide informed consent.

Exclusion

Pending incarceration in the next 30 days.
Plan to leave the area (Burlington/Chittenden County) in the next 30 days.
Physical, health, or structural challenge that prevents attendance at outpatient clinic.

What this trial measures

  • Intake at outpatient MOUD clinic30 days

    The proportion of participants who complete their initial (intake) outpatient MOUD clinic appointment after discharge from the emergency department.